Bayer Group Consolidated Statements of Changes in Equity

 

 

 

 

Accumulated total comprehensive income

 

 

 

 

Capital stock of Bayer AG

 

Capital reserves of Bayer AG

 

Retained earnings including net income

 

Exchange differences

Fair-value measurement of securities

Cash flow hedges

Revaluation surplus

 

Equity attributable to Bayer AG stockholders

 

Equity attributable to noncontrolling interest

 

Equity

 

 

€ million

 

€ million

 

€ million

 

€ million

€ million

€ million

€ million

 

€ million

 

€ million

 

€ million

Dec. 31, 2013

 

2,117

 

6,167

 

14,817

 

(2,545)

32

99

31

 

20,718

 

86

 

20,804

Equity transactions with owners

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital increase / decrease

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dividend payments

 

 

 

 

 

(1,737)

 

 

 

 

 

 

(1,737)

 

(2)

 

(1,739)

Other changes

 

 

 

 

 

6

 

 

 

 

(5)

 

1

 

 

 

1

Other comprehensive income

 

 

 

 

 

(3,538)

 

1,373

(2)

(135)

 

 

(2,302)

 

11

 

(2,291)

Income after income taxes

 

 

 

 

 

3,426

 

 

 

 

 

 

3,426

 

17

 

3,443

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dec. 31, 2014

 

2,117

 

6,167

 

12,974

 

(1,172)

30

(36)

26

 

20,106

 

112

 

20,218

Equity transactions with owners

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital increase / decrease

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dividend payments

 

 

 

 

 

(1,861)

 

 

 

 

 

 

(1,861)

 

(8)

 

(1,869)

Other changes

 

 

 

 

 

582

 

(155)

 

 

(5)

 

422

 

1,055

 

1,477

Other comprehensive income

 

 

 

 

 

776

 

705

(6)

13

 

 

1,488

 

33

 

1,521

Income after income taxes

 

 

 

 

 

4,110

 

 

 

 

 

 

4,110

 

(12)

 

4,098

Dec. 31, 2015

 

2,117

 

6,167

 

16,581

 

(622)

24

(23)

21

 

24,265

 

1,180

 

25,445